| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Almenoff June Sherie is a Director at BRAINSTORM CELL THERAPEUTICS INC. with holdings across 3 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $100K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | TENX Tenax Therapeutics, Inc. | Director | Buy | 1,993 | $7.50 | $14,944.78 | +2,143% | +62.4% | - | |
| Nov 13, 2024 | AVTX Avalo Therapeutics, Inc. | Director | Buy | 1,000 | $12.75 | $12,749.50 | +200.0% | -42.8% | +9.9% | |
| Jan 4, 2019 | BCLI Brainstorm Cell Therapeutics Inc. | Director | Buy | 1,475 | $3.39 | $5,000.25 | +25.9% | - | - |